Gallbladder cancer laboratory tests: Difference between revisions
No edit summary |
|||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Gallbladder cancer}} | {{Gallbladder cancer}} | ||
{{CMG}} | {{CMG}}{{AE}}{{PSD}} | ||
==Overview== | ==Overview== |
Revision as of 17:25, 25 August 2015
Gallbladder cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Gallbladder cancer laboratory tests On the Web |
American Roentgen Ray Society Images of Gallbladder cancer laboratory tests |
Risk calculators and risk factors for Gallbladder cancer laboratory tests |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
Laboratory findings consistent with the diagnosis of gallbladder cancer include abnormal liver function tests and elevated CA 19-9 and CEA levels.
Laboratory tests
Transabdominal ultrasound, CT scan, endoscopic ultrasound, MRI, MR cholangio-pancreatography (MRCP), CEA, CA 19-9 and liver function tests can be used for diagnosis. A biopsy is the only certain way to tell whether the tumorous growth is malignant or not
References